Clinical Study to Validate the Use of a New Point of Care Troponin I Test

NCT02620397 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1500

Last updated 2015-12-15

No results posted yet for this study

Summary

This trial is designed as a prospective, multi-center, observational study of "all-comers" eligible adult subjects presenting to participating emergency departments with symptoms suggestive of acute coronary syndrome (ACS)

Conditions

  • Acute Coronary Syndrome

Sponsors & Collaborators

  • Trinity Biotech

    lead INDUSTRY

Principal Investigators

  • Jim Rock · Trinity Biotech

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-03-31
Primary Completion
2015-10-31
Completion
2016-11-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02620397 on ClinicalTrials.gov